19-57840858-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001376223.1(ZNF587B):c.184G>T(p.Asp62Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001376223.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF587B | NM_001376223.1 | c.184G>T | p.Asp62Tyr | missense_variant | 3/3 | ENST00000594901.2 | NP_001363152.1 | |
ZNF587B | NM_001204818.2 | c.184G>T | p.Asp62Tyr | missense_variant | 3/4 | NP_001191747.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF587B | ENST00000594901.2 | c.184G>T | p.Asp62Tyr | missense_variant | 3/3 | 4 | NM_001376223.1 | ENSP00000469623.1 | ||
ZNF587B | ENST00000442832.8 | c.184G>T | p.Asp62Tyr | missense_variant | 3/4 | 2 | ENSP00000392410.2 | |||
ENSG00000268750 | ENST00000593873.6 | c.34-17718G>T | intron_variant | 4 | ENSP00000469133.2 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000576 AC: 8AN: 1389306Hom.: 0 Cov.: 33 AF XY: 0.00000584 AC XY: 4AN XY: 684872
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2024 | The c.184G>T (p.D62Y) alteration is located in exon 3 (coding exon 3) of the ZNF587B gene. This alteration results from a G to T substitution at nucleotide position 184, causing the aspartic acid (D) at amino acid position 62 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.